Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $30.2600 (-3.23%) ($30.2600 - $30.2600) on Fri. Apr. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.83% (three month average) | RSI | 46 | Latest Price | $30.2600(-3.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.2% a day on average for past five trading days. | Weekly Trend | IOVA advances 0.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(46%) XBI(42%) ARKG(41%) IWO(40%) IWC(38%) | Factors Impacting IOVA price | IOVA will decline at least -1.915% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-11%) TBT(-5%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.915% (StdDev 3.83%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $31.48 | 5 Day Moving Average | $31.32(-3.38%) | 10 Day Moving Average | $30.88(-2.01%) | 20 Day Moving Average | $31.48(-3.88%) | To recent high | -42.5% | To recent low | 5.6% | Market Cap | $4.431b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |